Table 1. Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study.
species | No | lineage | genotype | RD9 | TbD1 | pks15/1 | INH | RMP | PZA | EMB | SM |
M. tuberculosis | 9532/03 | Euro-American | Haarlem | + | − | − | s | s | s | s | s |
2336/02 | Euro-American | Haarlem | + | − | − | s | s | s | s | s | |
4130/02 | Euro-American | Haarlem | + | − | − | s | s | s | s | s | |
2333/99 | Euro-American | Uganda | + | − | − | s | s | s | s | s | |
2169/99 | Euro-American | Uganda | + | − | − | s | r | s | s | s | |
2191/99 | Euro-American | Uganda | + | − | − | s | s | s | s | s | |
1934/03 | East Asian | Beijing | + | − | + | s | s | s | s | s | |
1500/03 | East Asian | Beijing | + | − | + | s | s | s | s | s | |
12594/02 | East Asian | Beijing | + | − | + | s | s | s | s | s | |
4850/03 | Indo Oceanic | EAI | + | + | + | s | s | s | s | s | |
1797/03 | Indo Oceanic | EAI | + | + | + | s | s | s | s | s | |
947/01 | Indo Oceanic | EAI | + | + | + | s | s | s | s | s | |
M. africanum | 10517/01 | West-African 2 | WA2 | − | + | − | s | s | s | s | s |
5468/02 | West-African 2 | WA2 | − | + | − | s | s | s | s | s | |
10514/02 | West-African 2 | WA2 | − | + | − | r | s | s | s | s |
Molecular genotyping and drug sensitivity testing of Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study. Strain lineages are based on phylogenetic analysis by Gagneux et al. [86]. TbD1, RD9 and pks15/1 denote the presence or absence of previously reported phylogenetic markers [87], [88]. The Euro-American strains (Haarlem and Uganda genotypes) contain a 7bp deletion and W. African 2 strains contain a 6bp deletion in pks15/1. Abbreviations: EAI (East African Indian), WA2 (West African 2), INH (isoniazid), RMP (rifampicin), EMB (ethambutol), PZA (pyrazinamide), SM (streptomycin), s (sensitive), r (resistant).